uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04153711
查看IDENTITY
结构与身份
- 标准SMILES
- Cc1cc(=O)n(-c2ccccc2)[nH]1
- InChIKey
- KZQYIMCESJLPQH-UHFFFAOYSA-N
- 分子式
- C10H10N2O
- 平均分子量
- 174.2 g/mol
- 单同位素质量
- 174.07931295
COMPUTED
结构计算性质
- XLogP
- 1.8
- 极性表面积
- 32.3 Ų
- 氢键供体
- 1
- 氢键受体
- 2
- 可旋转键
- 1
- 重原子
- 13
- 形式电荷
- 0
- 复杂度
- 241
PROPERTIES
实验与物化性质
Melting Point
130 °C
Physical Description
Solid
PHARMACOLOGY
药理信息
Metabolism/Metabolites
Edaravone has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-(5-methyl-2-phenylpyrazol-3-yl)oxyoxane-2-carboxylic acid.;Norantipyrine is a known human metabolite of antipyrine.
Cellular Locations
Cytoplasm;Extracellular
USES
用途与制造
General Manufacturing Information
1H-Pyrazol-5-ol, 3-methyl-1-phenyl-: INACTIVE
ALIASES
名称与别名
REACTIONS
参与反应
uspto-grants-1981_04 · 10.6084/m9.figshare.5104873.v1 · US04260776
查看uspto-grants-1986_07 · 10.6084/m9.figshare.5104873.v1 · US04598020
查看Test data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D
查看uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看